Xact Kapitalforvaltning AB Has $3.72 Million Position in Cooper Companies Inc (COO)

Xact Kapitalforvaltning AB lowered its holdings in Cooper Companies Inc (NYSE:COO) by 6.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 13,432 shares of the medical device company’s stock after selling 877 shares during the quarter. Xact Kapitalforvaltning AB’s holdings in Cooper Companies were worth $3,723,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Sumitomo Life Insurance Co. increased its stake in Cooper Companies by 4.2% in the second quarter. Sumitomo Life Insurance Co. now owns 5,143 shares of the medical device company’s stock valued at $1,211,000 after acquiring an additional 206 shares during the period. Bronfman E.L. Rothschild L.P. increased its stake in Cooper Companies by 6.8% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 3,622 shares of the medical device company’s stock valued at $853,000 after acquiring an additional 232 shares during the period. Nomura Asset Management Co. Ltd. increased its stake in Cooper Companies by 1.3% in the second quarter. Nomura Asset Management Co. Ltd. now owns 19,770 shares of the medical device company’s stock valued at $4,655,000 after acquiring an additional 262 shares during the period. Intrust Bank NA increased its stake in Cooper Companies by 9.0% in the second quarter. Intrust Bank NA now owns 3,209 shares of the medical device company’s stock valued at $756,000 after acquiring an additional 265 shares during the period. Finally, Washington Capital Management Inc. increased its stake in Cooper Companies by 16.2% in the second quarter. Washington Capital Management Inc. now owns 2,150 shares of the medical device company’s stock valued at $506,000 after acquiring an additional 300 shares during the period. 97.07% of the stock is currently owned by institutional investors and hedge funds.

In other news, Director Allan E. Rubenstein sold 1,500 shares of the company’s stock in a transaction that occurred on Thursday, September 13th. The shares were sold at an average price of $265.37, for a total transaction of $398,055.00. Following the transaction, the director now directly owns 3,068 shares in the company, valued at $814,155.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Daniel G. Mcbride sold 10,310 shares of the company’s stock in a transaction that occurred on Thursday, September 13th. The stock was sold at an average price of $264.44, for a total transaction of $2,726,376.40. Following the transaction, the chief operating officer now owns 38,705 shares in the company, valued at $10,235,150.20. The disclosure for this sale can be found here. Insiders have sold 80,809 shares of company stock worth $20,740,667 over the last ninety days. Insiders own 1.60% of the company’s stock.

A number of analysts recently weighed in on COO shares. Zacks Investment Research cut shares of Cooper Companies from a “hold” rating to a “sell” rating in a research note on Monday, September 3rd. BMO Capital Markets upped their target price on shares of Cooper Companies from $280.00 to $285.00 and gave the company an “outperform” rating in a research note on Friday, August 31st. Raymond James upped their target price on shares of Cooper Companies from $270.00 to $300.00 and gave the company an “outperform” rating in a research note on Friday, September 21st. Oppenheimer set a $270.00 target price on shares of Cooper Companies and gave the company a “hold” rating in a research note on Friday, August 31st. Finally, ValuEngine raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a research note on Thursday, September 27th. Five research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $274.25.

Shares of Cooper Companies stock opened at $247.70 on Tuesday. The company has a current ratio of 2.58, a quick ratio of 1.54 and a debt-to-equity ratio of 0.70. The stock has a market cap of $12.18 billion, a price-to-earnings ratio of 21.93, a PEG ratio of 1.98 and a beta of 0.67. Cooper Companies Inc has a 1-year low of $216.47 and a 1-year high of $280.10.

Cooper Companies (NYSE:COO) last issued its quarterly earnings data on Thursday, August 30th. The medical device company reported $3.00 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $3.07 by ($0.07). The firm had revenue of $660.00 million for the quarter, compared to the consensus estimate of $653.44 million. Cooper Companies had a return on equity of 17.53% and a net margin of 5.23%. As a group, equities analysts anticipate that Cooper Companies Inc will post 11.62 EPS for the current year.

About Cooper Companies

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Further Reading: What is the yield curve?

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply